EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis

Béguelin, Wendy, Teater, Matt, Gearhart, Micah D., Calvo Fernández, María Teresa, Goldstein, Rebecca L., Cárdenas, Mariano G., Hatzi, Katerina, Rosen, Monica +11 more·2016·Cancer Cell
DOI 10.1016/j.ccell.2016.07.006

Cited by (258)

Items 201–258 of 258

  1. Epigenetic and metabolic reprogramming support plasma cell differentiation in germinal centers
    Yuliang Wang, Xinyi Yang, Mengting Lou, Tiantian Chen, Wen Li, Cuifang Yang, Le Zhang, Zhenming Cai, Yuren Fan, Sulan Zhai et al. · 2026 · The Journal of Experimental Medicine
  2. The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy
    Myrna Candelaria · 2026 · Frontiers in Oncology
  3. Epigenetic mechanisms in health and disease: BCEC 2017
    Albert Carbonell, Raquel Fueyo, Andrea Izquierdo‐Bouldstridge, Cristina Moreta-Moraleda, Albert Jordan · 2018 · Epigenetics
  4. CHROMO domain readers: A rainbow of opportunities
    Xueqin Sherine Sun, Padmina Shrestha, Alea A. Mills · 2023 · Elsevier eBooks
  5. The 3D Genome: EZH2 Comes into the Fold
    Gerard L. Brien, Adrian P. Bracken · 2019 · Trends in Molecular Medicine
  6. EZH2 inhibition results in genome-wide PRC2 redistribution
    Chih-Chi Yuan, Ah‐Jung Jeon, Greg Tucker‐Kellogg, Barbara M. Bryant, Patrick Trojer · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation
    Janneke G. C. Peeters, Stephanie L. Silveria, Merve Özdemir, Srinivas Ramachandran, Michel J.P. DuPage · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Connecting the DOT1L: it’s EZH2
    Richard Eric Davis · 2025 · Blood
  9. Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fate
    Alexia Martínez de Paz, Christopher R. Chin, Mythili Ketavarapu, Yuchen Sun, Matthew R. Marunde, Jeremy T.-H. Chang, Laiba F Khan, John Cohen, Rui Yang, Michael J. Bale et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. DNA and Histone Methylation in Hematopoietic Malignancy
    Kimihito Cojin Kawabata, Toshio Kitamura · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
  11. Genetic and epigenetic mechanisms underlying the regulation of flowering time
    Lejon E. M. Kralemann · 2019 · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
  12. Protein kinase D1 phosphorylates CBX8 to facilitate the disassociation of PRC1 complex from p16 promoter and promotes cell senescence
    Yuanyuan Su, Yao Liang, Chenzhong Xu, Na Zhang, Doudou Liu, Guodong Li, Tanjun Tong, Jun Chen · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Molecular Genetics in Indolent Lymphomas
    Jude Fitzgibbon, Oliver Weigert · 2021 · Hematologic malignancies
  14. Direct recruitment of BCOR by AF9 forms a fuzzy complex required for MLL-AF9 leukemogenesis
    Charles Schmidt · 2017
  15. Faculty Opinions recommendation of NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells.
    Jason M. Butler · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  16. In This Issue
    2022 · Blood Cancer Discovery
  17. Genômica funcional: engenharia reversa por meio de métodos de altaperformance na saliva e sangue de pacientes com síndrome de Sjögren
    Giovanna Piacenza Florezi · 2022
  18. BCL6 is a context-dependent mediator of the glioblastoma therapy response
    Anna K.W. Tribe · 2023
  19. The Role of Epigenetic Dysregulation in Lymphoma Biology
    Qing Deng and, Michael R. Green · 2023
  20. TdT-positive high-grade B-cell lymphoma with BCOR and IDH1 mutations
    Yu‐Ting Yu, Kuan-Yu Lin, Yaping Chen, Yilin Chen, Leonard Jeffrey Medeiros, Kung‐Chao Chang · 2023 · Pathology
  21. Molekulargenetik bei indolenten Lymphomen
    Jude Fitzgibbon, Oliver Weigert · 2023 · Springer eBooks
  22. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo
    Yajing Xing, Weikai Guo, Min Yi Wu, Jiuqing Xie, Dongxia Huang, Pan Hu, Miaoran Zhou, Qiansheng Zhang, Peili Wang, Xin Wang et al. · 2024
  23. Molecular Pathogenesis of B-Cell Lymphomas
    Laura Pasqualucci, Pantaleo De Simone, Riccardo Dalla‐Favera · 2024 · Elsevier eBooks
  24. Precision Medicine in Diffuse Large B-Cell Lymphoma
    Siba El Hussein, Francisco Vega · 2023 · Molecular pathology library
  25. Developmental Stage and Cellular Context Determine Oncogenic and Molecular Outcomes of Ezh2 Y641F Mutation in Hematopoiesis
    Sarah M. Zimmerman, Samantha J. Procasky, Sofia R Smith, Jieyu Liu, Chad Torrice, George P. Souroullas · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Dual targeting of EZH2 and DOT1L in DLBCL
    Jérôme Moreaux · 2025 · Blood
  27. Small Molecule Inhibitors Targeting Protein–Protein Interactions in the BCL Protein
    Wenhua Zhu, Yangbo He, Gang Chen, Di Zhu · 2025 · Wiley eBooks
  28. Additional file 8 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Chengcheng Wang, Zhao, Yupei · 2021 · Figshare
  29. Additional file 5 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Wang, Chengcheng, Zhao, Yupei · 2021 · Figshare
  30. Additional file 7 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Wang, Chengcheng, Zhao, Yupei · 2021 · Figshare
  31. Additional file 6 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Chengcheng Wang, Zhao, Yupei · 2021 · Figshare
  32. Additional file 11 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Wang, Chengcheng, Zhao, Yupei · 2021 · Figshare
  33. Additional file 1 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2023 · Figshare
  34. Additional file 10 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Wang, Chengcheng, Zhao, Yupei · 2021 · Figshare
  35. Additional file 12 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Wang, Chengcheng, Zhao, Yupei · 2021 · Figshare
  36. Additional file 3 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  37. Additional file 4 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  38. Additional file 9 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
    Chen, Yuan, Xu, Ruiyuan, Rexiati Ruze, Yang, Jinshou, Wang, Huanyu, Jianlu Song, You, Lei, Wang, Chengcheng, Zhao, Yupei · 2021 · Figshare
  39. Additional file 2 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  40. Additional file 5 of Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Lin, Xiang, Chen, Ji-Dong, Wang, Chen-Yu, Cai, Zhen, Zhan, Rui, Yang, Chen, Zhang, La-Ying, Li, Lian-Yun, Xiao, Yong, Chen, Ming-Kai et al. · 2024 · Figshare
  41. Identification of a neoplastic Tfh-like cellular subset in a mouse model of angioimmunoblastic T cell lymphoma
    Saba Mohammaei, Jiyeon Lee, Antoine Bouchard, Evany Bernal Ballesteros, Nikoletta Diamantopoulos, Lifei Hou, Eileen Remold‐O’Donnell, Junhun Cho, Woong‐Kyung Suh · 2026 · Frontiers in Oncology
  42. Conséquences cliniques et moléculaires de la marque H3K27 me3 HIST1 dans les leucémies aigües myéloïdes sans anomalies cytogénétiques
    Sylvain Garciaz · 2018 · theses.fr (ABES)
  43. Rôle de l'inactivation du régulateur épigénétique KMT2D dans le développement du lymphome follicullaire
    Gabriel Brisou · 2020 · theses.fr (ABES)
  44. Etude de l'implication de mécanismes épigénétiques dans la physiopathologie du myélome multiple et dans la différenciation plasmocytaire normale
    Laurie Herviou · 2018 · theses.fr (ABES)
  45. Anomalies moléculaires dans la macroglobulinémie de Waldenström : identification d’une mutation somatique récurrente dans le gène codant pour le facteur de transcription SPI1/PU.1 et description de ses conséquences fonctionnelles
    Damien Roos‐Weil · 2018
  46. Epigenome deregulation in Epstein Barr virus-induced oncogenic B cell transformation
    Francesca Manara · 2023 · theses.fr (ABES)
  47. Modélisation de la réponse thérapeutique du lymphome folliculaire grâce à un modèle 3D organoïde
    Narimène Houmera · 2023
  48. Molecular Pathogenesis and Therapeutic Response of Diffuse Large B Cell Lymphoma Genetic Subtypes
    J. D. Phelan, Julius Christoph Enssle, Sean R. Corcoran, George W. Wright, Louis M. Staudt · 2026 · Annual Review of Cancer Biology
  49. Unraveling the layers of epigenetic control in respiratory antiviral defense
    Matthew I. McFadden, Bryan Simo, Adriana Forero · 2026 · Journal of Virology
  50. DOT1L shapes ncPRC1 target gene repression to maintain germinal center B-cell identity in diffuse large B-cell lymphoma
    Camiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, Marnix H. P. de Groot, Stijn F.K. Kneefel, Maaike Kreft, Hendrik J. Kuiken, Cor Lieftink, Nils Eickhoff, Liesbeth Hoekman et al. · 2026 · Blood
  51. Mouse models of B cell lymphomas on the basis of genetic features
    Min Yuan, James Q. Wang · 2026 · Frontiers in Immunology
  52. Comparative Analysis of the Clinicopathological Features of Follicular Lymphoma With and Without EZH2 Y646 Mutation
    Akira Satou, Kanae Yoshikawa, Ikki Mitsuda, Akari Iwakoshi, Makoto Minoshima, Masaharu Gunji, Hideki Murakami, Joaquim Carreras, Haruka Ikoma, Naoya Nakamura et al. · 2026 · Pathology International
  53. Intravital single-cell behavior profiling reveals disrupted germinal center B cell motility and interactions by EZH2 gain-of-function mutation
    Chanhong Min, Kibaek Choe, Xi Chen, Ioannis Karagiannidis, Nikita Sivakumar, Chris Xu, Ari Melnick, Jude M. Phillip, Wendy Béguelin · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Recent Advances in Chronic Myeloid Leukaemia (CML): Emerging Molecular and Immunotherapeutic Targets
    Jingyi Dai, Panpan Zheng, Jian Liu, Linyan Cheng, Xiao Wei Zheng, Lujun Chen, Jingting Jiang, Zhuojun Zheng · 2026 · Frontiers in Bioscience-Landmark
  55. BCOR Biology in Development and Cancer
    Hitomi N. Royston, Alberto Taddia, Fabio R. Santori, Natalia Ivanova, Kosuke Funato · 2026 · Cells
  56. Epigenetic regulation of humoral immunity: molecular mechanisms, diseases and therapeutic targets
    Shaocun Zhang, Wang Zhi Yu, Xin Min, Yuzhang Wu, Wanli Liu · 2026 · Signal Transduction and Targeted Therapy
  57. Deep dynamical models of single-cell multiomic velocities predict loss-of-function and rescue perturbations in B cells
    Alireza Karbalayghareh, Benedikt Pelzer, Christopher R. Chin, Ari M. Melnick, Darko Barišić, Christina S. Leslie · 2026 · Nature Biotechnology
  58. BindingDB Entry 50017482: B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.
    BindingDB · 2023 · UC San Diego